Palisade Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-21,614
| Closed | -$1.53M | – | 520 |
|
|
2016
Q3 | $1.53M | Sell |
21,614
-3,151
| -13% | -$223K | 0.05% | 368 |
|
|
2016
Q2 | $1.21M | Buy |
24,765
+6,589
| +36% | +$322K | 0.04% | 395 |
|
|
2016
Q1 | $1.15M | Buy |
18,176
+12,889
| +244% | +$816K | 0.04% | 409 |
|
|
2015
Q4 | $593K | Sell |
5,287
-6,274
| -54% | -$704K | 0.02% | 461 |
|
|
2015
Q3 | $1.11M | Sell |
11,561
-42,151
| -78% | -$4.06M | 0.03% | 400 |
|
|
2015
Q2 | $5.5M | Sell |
53,712
-1,269
| -2% | -$130K | 0.14% | 255 |
|
|
2015
Q1 | $3.41M | Buy |
+54,981
| New | +$3.41M | 0.09% | 307 |
|